Center for Health Services Research, Department of Family Medicine, The Larner College of Medicine, University of Vermont, Burlington.
Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts.
JAMA Neurol. 2020 Jul 1;77(7):863-871. doi: 10.1001/jamaneurol.2020.0770.
Over the last decade or so, there have been substantial investments in the development of stroke systems of care to improve access and quality of care in rural communities. Whether these have narrowed rural-urban disparities in care is unclear.
To describe trends among rural and urban patients with acute ischemic stroke or transient ischemic attack in the type of health care centers to which patients were admitted, what care was provided, and the outcomes patients experienced.
DESIGN, SETTING, AND PARTICIPANTS: This descriptive observational study included 100% claims for beneficiaries of traditional fee-for-service Medicare from 2008 through 2017. All rural and urban areas in the US were included, defined by whether a beneficiary's residential zip code was in a metropolitan or nonmetropolitan area. All admissions in the US among patients with traditional Medicare who had a transient ischemic attack or acute stroke (N = 4.01 million) were eligible to be included in this study. Admissions for beneficiaries with end-stage kidney disease (n = 85 927 [2.14%]), beneficiaries with unidentified Rural-Urban Commuting Area codes (n = 12 797 [0.32%]), and beneficiaries not continuously enrolled in traditional Medicare in the 12 months before and 3 months after their admission (n = 442 963 [11.0%]) were excluded.
Residence in an urban or rural area; admission to a hospital with a transient ischemic attack or acute stroke.
Discharge from a certified stroke center, receiving a neurology consultation during admission, treatment with alteplase, days institutionalized, and 90-day mortality.
The final sample included 3.47 million admissions from 2008 through 2017. In this sample, 2.01 million patients (58.0%) were female, and the mean (SD) age was 78.6 (10.5) years. In 2008, 24 681 patients (25.2%) and 161 217 patients (60.6%) in rural and urban areas, respectively, were cared for at a certified stroke center (disparity, -35.4%). By 2017, this disparity was -26.6%, having narrowed by 8.7 percentage points (95% CI, 6.6-10.8 percentage points). There was also narrowing in the rural-urban disparity in neurologist evaluation during admission (6.3% [95% CI, 4.2%-8.4%]). However, the rural-urban disparity widened or was similar with regard to receiving alteplase (0.5% [95% CI, 0.1%-0.8%]), mean days in an institution from admission (0.5 [95% CI, 0.2-0.8] days), and mortality at 90 days (0.3% [95% CI, -0.02% to 0.6%]), respectively.
In the last decade, care for rural residents with acute ischemic stroke and transient ischemic attack has shifted to certified stroke centers and now more likely includes neurologist input. However, disparities in access to treatments, such as alteplase, and outcomes persist, highlighting that work still is needed to extend improvements in stroke care to all US residents.
在过去的十年左右,为改善农村社区的护理可及性和护理质量,对卒中护理系统进行了大量投资。这些投资是否缩小了城乡护理差距尚不清楚。
描述农村和城市急性缺血性卒中和短暂性脑缺血发作患者在接受治疗的医疗保健中心类型、接受的护理以及患者经历的结局方面的趋势。
设计、设置和参与者:这是一项描述性观察性研究,纳入了 2008 年至 2017 年接受传统按服务项目付费医疗保险的受益人的 100%索赔。美国所有的农村和城市地区都包括在内,定义为受益人的居住邮政编码是否位于大都市区或非大都市区。在美国,所有接受传统医疗保险的有短暂性脑缺血发作或急性卒中年满 18 岁的患者(N=401 万)都有资格纳入本研究。符合以下条件的患者除外:终末期肾病(n=85927[2.14%])、农村-城市通勤区代码不明(n=12797[0.32%])和患者在入院前 12 个月和入院后 3 个月内未连续参加传统医疗保险(n=442963[11.0%])。
居住在城市或农村地区;入住有短暂性脑缺血发作或急性卒中的医院。
从认证卒中中心出院、在入院期间接受神经病学咨询、接受阿替普酶治疗、住院天数和 90 天死亡率。
最终样本包括 2008 年至 2017 年的 347 万次入院。在该样本中,201 万名患者(58.0%)为女性,平均(SD)年龄为 78.6(10.5)岁。2008 年,农村和城市地区分别有 24681 名(25.2%)和 161217 名(60.6%)患者在认证卒中中心接受治疗(差异,-35.4%)。到 2017 年,这一差距缩小了 26.6%,缩小了 8.7 个百分点(95%CI,6.6%-10.8 个百分点)。在入院期间接受神经病学家评估方面,城乡差距也有所缩小(6.3%[95%CI,4.2%-8.4%])。然而,在接受阿替普酶治疗(0.5%[95%CI,0.1%-0.8%])、入院后平均住院天数(0.5[95%CI,0.2-0.8]天)和 90 天死亡率(0.3%[95%CI,-0.02%至 0.6%])方面,城乡差距仍在扩大或相似。
在过去的十年中,农村地区急性缺血性卒中和短暂性脑缺血发作患者的护理已转向认证卒中中心,现在更可能包括神经病学方面的意见。然而,获得治疗方法(如阿替普酶)和结局方面的差异仍然存在,这表明仍需要努力将卒中护理的改善扩展到所有美国居民。